Back to search

Thalidomide for managing cancer cachexia

Data up to Jan 2025

Published2012
Citations96
References63

Total Citations Per Year

Abstract

References (63)

Measuring inconsistency in meta-analyses

2003 • 53,662 citations

Meta-analysis in clinical trials

1986 • 36,193 citations

Cochrane Handbook for Systematic Reviews of Interventions

2008 • 18,785 citations

Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0. The Cochrane Collaboration

2013 • 5,537 citations

Definition and classification of cancer cachexia: an international consensus

2011 • 4,715 citations

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

1998 • 4,679 citations

The clinical evaluation of chemotherapeutic agents in cancer

1949 • 2,793 citations

Meta-analysis: Principles and procedures

1997 • 2,277 citations

Consensus definition of sarcopenia, cachexia and pre-cachexia: Joint document elaborated by Special Interest Groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics”

2010 • 1,587 citations

Systematic Reviews in Health Care. Meta-analysis in Context.

2002 • 1,441 citations

Mechanisms of Cancer Cachexia

2009 • 1,102 citations

Cachexia in cancer patients

2002 • 953 citations

Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis

2006 • 744 citations

Effect of a protein and energy dense n-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial

2003 • 590 citations

Cancer Anorexia-Cachexia Syndrome: Current Issues in Research and Management

2002 • 579 citations

Cancer cachexia: Developing multimodal therapy for a multidimensional problem

2008 • 428 citations

Evaluation of Chemotherapeutic Agents.

1950 • 393 citations

Cachexia

2000 • 378 citations

Further validation of the multidimensional fatigue symptom inventory-short form

2004 • 345 citations

Cancer anorexia-cachexia syndrome: are neuropeptides the key?

1999 • 345 citations

Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial

2005 • 312 citations

Therapy Insight: cancer anorexia–cachexia syndrome—when all you can eat is yourself

2005 • 310 citations

Muscle Wasting in Cancer Cachexia: Clinical Implications, Diagnosis, and Emerging Treatment Strategies

2010 • 309 citations

Eicosapentaenoic acid (EPA, an omega-3 fatty acid from fish oils) for the treatment of cancer cachexia

2007 • 257 citations

Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia.

1993 • 227 citations

Megestrol acetate for treatment of anorexia-cachexia syndrome

2005 • 206 citations

Randomized Phase III Clinical Trial of Five Different Arms of Treatment in 332 Patients with Cancer Cachexia

2010 • 206 citations

Cancer anorexia-cachexia syndrome: cytokines and neuropeptides

2004 • 190 citations

Thalidomide in patients with cachexia due to terminal cancer: Preliminary report

1999 • 128 citations

The experience of cancer cachexia: A qualitative study of advanced cancer patients and their family members

2008 • 125 citations

Anticytokine approaches to the treatment of anorexia and cachexia.

1998 • 101 citations

Oesophageal cancer and cachexia: the effect of short‐term treatment with thalidomide on weight loss and lean body mass

2003 • 97 citations

Randomized phase III clinical trial of five different arms of treatment for patients with cancer cachexia: interim results

2008 • 97 citations

Fighting Over Food: Patient and Family Understanding of Cancer Cachexia

2009 • 80 citations

Palliative Medicine: A Case-Based Manual

2021 • 69 citations

Randomized Double-Blind Placebo-Controlled Trial of Thalidomide in Combination With Gemcitabine and Carboplatin in Advanced Non–Small-Cell Lung Cancer

2009 • 67 citations

The Cancer Anorexia–Cachexia Syndrome

2002 • 65 citations

Topics in Palliative Care

1997 • 63 citations

Physical activity level as an outcome measure for use in cancer cachexia trials: a feasibility study

2009 • 63 citations

PHASE II STUDY OF PACLITAXEL AND CISPLATIN FOR ADVANCED UROTHELIAL CANCER

2000 • 61 citations

Primary caregiver perceptions of intake cessation in patients who are terminally Ill.

1997 • 59 citations

Toxicity profile of the immunomodulatory thalidomide analogue, lenalidomide: Phase I clinical trial of three dosing schedules in patients with solid malignancies

2006 • 51 citations

Time‐Dependent Variation in Weight and Body Composition in Healthy Adults

2000 • 50 citations

Research methodology: cancer cachexia syndrome

2004 • 49 citations

The Pathophysiology and Treatment of Cancer Cachexia

2002 • 48 citations

Update on emerging drugs for cancer cachexia

2009 • 46 citations

Randomised phase III clinical trial of 5 different arms of treatment on 332 patients with cancer cachexia.

2010 • 44 citations

Thalidomide: a new anticancer drug?

2003 • 38 citations

Poor tolerability of thalidomide in end-stage oesophageal cancer

2011 • 33 citations

Cancer cachexia therapy: a key weapon in the fight against cancer

2011 • 27 citations

Incidence and Costs of Acute Medical Conditions in Long-Stay Incontinent Nursing Home Residents

2003 • 19 citations

Low tolerance and high toxicity of thalidomide as maintenance therapy after double autologous stem cell transplant in multiple myeloma patients

2006 • 16 citations

On the Natural Laws of Muscular Exertion

1870 • 13 citations

Thalidomide and cancer cachexia: old problem, new hope?

2005 • 12 citations

Thalidomide in the Treatment of Cancer Cachexia

2008 • 11 citations

Palliative care from the beginning of treatment for advanced pancreatic cancer. Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010.

2010 • 6 citations

The problem of weakness in patients with advanced cancer

1999 • 6 citations

Thalidomide Celgene Corp.

1998 • 4 citations

Adiponectin and insulin resistance associated with endometrial cancer

2006 • 3 citations

Nuevos fármacos potencialmente útiles para el tratamiento de la caquexia en cuidados paliativos

2001 • 2 citations

67 Malignant mesothelioma (MM) and cachexia. Description of body composition changes in 27 patients receiving chemotherapy and/or thalidomide treatment

2006 • 1 citations

Thalidomide: an effective anabolic agent in gastrointestinal cancer cachexia: authors’ reply

2006 • 1 citations

Gemcitabine (G) and Doxorubicin (DXR) as first-line treatment of metastatic breast cancer (MBC): Preliminary results

2004 • 1 citations

Cited By (0)

Loading...